Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari M Melnick

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Nature Immunology|December 13, 2018
Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesisKaterina Hatzi, Huimin Geng, Ashley S Doane, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomasJie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
The Journal of Experimental Medicine|September 14, 2011
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemiaChristian Hurtz, Katerina Hatzi, Leandro Cerchietti, et al.
Cancer Discovery|June 3, 2022
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCLMin Xia, Liron David, Matt Teater, et al.
Cancer Cell|June 12, 2019
Non-oncogene Addiction to SIRT3 Plays a Critical Role in LymphomagenesisMeng Li, Ying-Ling Chiang, Costas A Lyssiotis, et al.
Plos One|October 26, 2020
Targeted detection and quantitation of histone modifications from 1,000 cellsNebiyu A Abshiru, Jacek W Sikora, Jeannie M Camarillo, et al.
Science Translational Medicine|June 30, 2017
Genetic and epigenetic inactivation of <i>SESTRIN1</i> controls mTORC1 and response to EZH2 inhibition in follicular lymphomaElisa Oricchio, Natalya Katanayeva, Maria Christine Donaldson, et al.
Nature Immunology|January 9, 2025
IRE1α-XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programsBrendan M Barton, Francheska Son, Akanksha Verma, et al.
Cancer Discovery|February 5, 2021
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental SignaturesNikita Kotlov, Alexander Bagaev, Maria V Revuelta, et al.
Cancer Discovery|January 27, 2021
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML RecurrenceCihangir Duy, Meng Li, Matt Teater, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Nature Immunology|December 13, 2018
Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesisKaterina Hatzi, Huimin Geng, Ashley S Doane, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomasJie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
The Journal of Experimental Medicine|September 14, 2011
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemiaChristian Hurtz, Katerina Hatzi, Leandro Cerchietti, et al.
Cancer Discovery|June 3, 2022
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCLMin Xia, Liron David, Matt Teater, et al.
Cancer Cell|June 12, 2019
Non-oncogene Addiction to SIRT3 Plays a Critical Role in LymphomagenesisMeng Li, Ying-Ling Chiang, Costas A Lyssiotis, et al.
Plos One|October 26, 2020
Targeted detection and quantitation of histone modifications from 1,000 cellsNebiyu A Abshiru, Jacek W Sikora, Jeannie M Camarillo, et al.
Science Translational Medicine|June 30, 2017
Genetic and epigenetic inactivation of <i>SESTRIN1</i> controls mTORC1 and response to EZH2 inhibition in follicular lymphomaElisa Oricchio, Natalya Katanayeva, Maria Christine Donaldson, et al.
Nature Immunology|January 9, 2025
IRE1α-XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programsBrendan M Barton, Francheska Son, Akanksha Verma, et al.
Cancer Discovery|February 5, 2021
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental SignaturesNikita Kotlov, Alexander Bagaev, Maria V Revuelta, et al.
Cancer Discovery|January 27, 2021
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML RecurrenceCihangir Duy, Meng Li, Matt Teater, et al.
Pageof 15